VISTERRA
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
VISTERRA
Industry:
Biotechnology Clinical Trials Health Diagnostics Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.visterrainc.com
Total Employee:
51+
Status:
Active
Contact:
6174981073
Total Funding:
125.39 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps
Similar Organizations
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
ProMIS Neurosciences
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
TWO CELLS Co.,Ltd
TWO CELLS is engaged in the research and development of regeneration technology.
Current Advisors List
Board_observer
2012-01-01
Board_observer
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Brian Pereira President & CEO & Board Member @ Visterra
President & CEO & Board Member
2013-07-01
Peter Courossi Chief Financial Officer @ Visterra
Chief Financial Officer
2010-01-01
Steven Brugger Chief Executive Officer @ Visterra
Chief Executive Officer
2010-11-01
Kamran Tavangar Vice President, Strategic Product Development @ Visterra
Vice President, Strategic Product Development
2011-01-01
Zachary Shriver Chief Scientific Officer @ Visterra
Chief Scientific Officer
Mark Boshar Vice President, Legal @ Visterra
Vice President, Legal
Kevin Bitterman Director @ Visterra
Director
Founder
Investors List
Flagship Pioneering
Flagship Pioneering investment in Series C - Visterra
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series C - Visterra
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Visterra
Polaris Partners
Polaris Partners investment in Series C - Visterra
Vertex Ventures HC
Vertex Ventures HC investment in Series C - Visterra
Cycad Group
Cycad Group investment in Series C - Visterra
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Visterra
Allegheny Financial Group
Allegheny Financial Group investment in Series C - Visterra
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series C - Visterra
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Series C - Visterra
Official Site Inspections
http://www.visterrainc.com Semrush global rank: 9.06 M Semrush visits lastest month: 445
- Host name: ip-173-201-180-75.ip.secureserver.net
- IP address: 173.201.180.75
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Visterra"
Home - Visterra
Visterra is a biologics research and early-stage clinical development company developing therapies for patients with immune-mediated and other hard-to-treat diseases.See details»
Otsuka | Visterra, Inc. - Otsuka America
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat …See details»
Our Vision - Visterra
As a member of the Otsuka family of companies, we are uniquely positioned as a small, dynamic, nimble and innovative organization where individuals and teams are empowered to make big …See details»
Leadership Team - Visterra
As Vice President, Research, Karthik Viswanathan provides leadership to several discovery programs and is responsible for Visterra’s computational and protein engineering platforms.See details»
Visterra Inc. - LinkedIn
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat...See details»
Otsuka Pharmaceutical Co., Ltd. - 大塚製薬株式会社
Jul 11, 2018 · Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and …See details»
Visterra - Crunchbase Company Profile & Funding
Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts. An investigational humanized IgG2 monoclonal antibody being evaluated for the treatment of IgA nephropathy (IgAN), a chronic, progressive kidney disease.See details»
Visterra, Inc. Company Profile | Waltham, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Visterra, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Pereira, Brian J. G., MD - Visterra
As President and Chief Executive Officer, Brian Pereira oversees all aspects of Visterra and its interactions with the parent the company Otsuka, including research & development, accounting & finance, legal, pharmaceutical …See details»
Otsuka Pharmaceutical to Acquire Visterra | Flagship Pioneering
Jul 11, 2018 · Tokyo, Japan and Waltham, Mass., July 11, 2018 — Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Visterra, Inc. (Visterra) announce that they have entered into a definitive …See details»
Otsuka Pharmaceutical to Acquire Visterra - Pharma's Almanac
Jul 12, 2018 · TOKYO & WALTHAM, Mass.-- (BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Visterra, Inc. (Visterra) announce that they have entered into a definitive …See details»
Visterra Company Profile 2024: Valuation, Investors ... - PitchBook
Operator of a clinical-stage biopharmaceutical company designed to treat infectious diseases caused by organisms.See details»
Visterra CEO and Key Executive Team | Craft.co
Visterra's key executives include Greg Babcock and 9 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API. …See details»
Visterra - Overview, News & Similar companies | ZoomInfo.com
Nov 1, 2023 · Visterra contact info: Phone number: (617) 498-1070 Website: www.visterrainc.com What does Visterra do? Visterra is a biologics research and early-stage clinical development …See details»
Contact - Visterra
For general information: info@visterrainc.com. For partnering: bd@visterrainc.com. For patients: clinicaltrials@visterrainc.com . Phone: (617) 498-1070See details»
Visterra - Devex
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody …See details»
Visterra Company Profile - Office Locations, Competitors ... - Craft
Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody …See details»
Our Culture - Visterra
Visterra Volunteers is the corporate social responsibility committee for Visterra. Our mission is to make philanthropic and charitable activities fun and accessible for everyone in the company. …See details»
Working at Visterra - Glassdoor
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat …See details»
Our Approach - Visterra
Located in the greater Cambridge/Boston area, we are an active part of the area’s vibrant research ecosystem, with multiple partnerships and productive collaborations with leading …See details»